PinkDx Revenue and Competitors
Estimated Revenue & Valuation
- PinkDx's estimated annual revenue is currently $3.2M per year.
- PinkDx's estimated revenue per employee is $140,000
- PinkDx's total funding is $45M.
Employee Data
- PinkDx has 23 Employees.
- PinkDx grew their employee count by 92% last year.
PinkDx's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder, CEO & Chairwoman | Reveal Email/Phone |
2 | Co-Founder and Chief Scientific Officer | Reveal Email/Phone |
3 | Co-founder & CFO | Reveal Email/Phone |
4 | Co-founder & CSO | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | Chief Medical Officer | Reveal Email/Phone |
7 | VP Clinical Operations | Reveal Email/Phone |
8 | Senior Clinical Trial Manager | Reveal Email/Phone |
9 | Scientist | Reveal Email/Phone |
10 | Sr. Bioinformatics Scientist | Reveal Email/Phone |
PinkDx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.2M | 23 | 92% | $45M | N/A |
What Is PinkDx?
PinkDx is an early-stage company whose vision is to\npositively impact the health of women throughout\ntheir life journey.\n\nWe focus on addressing the medical problems that women uniquely face by applying sophisticated scientific approaches to resolve them and provide answers that have an immediate, positive impact on their lives. Our first indication will focus on overcoming diagnostic challenges for women who present with general symptoms that could signal a gynecological cancer. \n\nLed by a team of diagnostics industry veterans, PinkDx is privately held, with funding from prominent biotechnology investors, including Catalio Capital Management, The Production Board, Mountain Group Partners, Byers Capital and Mayo Clinic.
keywords:N/A$45M
Total Funding
23
Number of Employees
$3.2M
Revenue (est)
92%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.7M | 23 | -15% | $4.1M |
#2 | $2.3M | 23 | N/A | N/A |
#3 | $1.7M | 23 | 0% | $52M |
#4 | $2.3M | 23 | N/A | N/A |
#5 | $2.3M | 23 | N/A | N/A |